Resmed (RSMDF) Dividends Paid - Common (2012 - 2026)
Resmed's (RSMDF) quarterly Dividends Paid - Common came in at $87.1 million in Q2 2026, up 12.24% on a YoY basis from $77.6 million in Q2 2025, and little changed quarter-over-quarter from $87.2 million in Q1 2026.
Analysis
Resmed (RSMDF) Dividends Paid - Common (2012 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Dividends Paid - Common for 15 consecutive years, with $87.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Dividends Paid - Common rose 12.24% year-over-year to $87.1 million; the trailing twelve-month figure through Jun 2026 stood at $349.7 million (up 12.47% YoY), and the FY2026 full-year result was $349.7 million, up 12.47% from the prior year.
- Dividends Paid - Common held at $87.1 million in Q2 2026 per RSMDF's latest filing, from $87.2 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $87.8 million in Q3 2025 and bottomed at $61.4 million in Q1 2022.
- Historically, Dividends Paid - Common has averaged $73.6 million across 5 years, with a median of $70.6 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Dividends Paid - Common increased 5.23% in 2023, then gained 12.73% in 2025.
- Over 5 years, Dividends Paid - Common stood at $64.5 million in 2022, then advanced by 9.58% to $70.7 million in 2023, then gained by 9.93% to $77.7 million in 2024, then climbed by 12.73% to $87.6 million in 2025, then fell by 0.56% to $87.1 million in 2026.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $87.1 million, $87.2 million, and $87.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 1.10 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 921.00 Mn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 337.00 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 61.40 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 87.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 87.09 Mn |
| Mar 31, 2026 | 87.24 Mn |
| Dec 31, 2025 | 87.58 Mn |
| Sep 30, 2025 | 87.75 Mn |
| Jun 30, 2025 | 77.59 Mn |
| Mar 31, 2025 | 77.70 Mn |
| Dec 31, 2024 | 77.70 Mn |
| Sep 30, 2024 | 77.89 Mn |
| Jun 30, 2024 | 70.55 Mn |
| Mar 31, 2024 | 70.49 Mn |
| Dec 31, 2023 | 70.68 Mn |
| Sep 30, 2023 | 70.60 Mn |
| Jun 30, 2023 | 64.71 Mn |
| Mar 31, 2023 | 64.64 Mn |
| Dec 31, 2022 | 64.50 Mn |
| Sep 30, 2022 | 64.43 Mn |
| Jun 30, 2022 | 61.49 Mn |
| Mar 31, 2022 | 61.42 Mn |
| Dec 31, 2021 | 61.25 Mn |
| Sep 30, 2021 | 61.19 Mn |